428 filings
Page 7 of 22
8-K
z7b819o76
2 Nov 22
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022
8:05am
8-K
4gk00 h8u13u
24 Oct 22
Morphic Announces Complete Enrollment of EMERALD-1 Main Cohort Ahead of Projections
8:01am
8-K
4fzass8mxqxn
3 Aug 22
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022
8:05am
8-K
7cic3bkcd om3
21 Jun 22
Termination of a Material Definitive Agreement
4:15pm
4
mzy8h5xl
10 Jun 22
Morphic Holding / SUSANNAH GRAY ownership change
7:00pm
4
wyhs5wbfq544lv9rkcs
10 Jun 22
Morphic Holding / JOSEPH P SLATTERY ownership change
7:00pm
4
w8oiqn4prq9ezo
10 Jun 22
Morphic Holding / Amir Nashat ownership change
7:00pm
4
lybfnw4b
10 Jun 22
Morphic Holding / TIMOTHY A SPRINGER ownership change
7:00pm
4
pavyltw4kzqa8lkjb9
10 Jun 22
Morphic Holding / Nisha Nanda ownership change
7:00pm
4
vn1upv8mdn ef2blnsfw
10 Jun 22
Morphic Holding / Martin Edwards ownership change
7:00pm
4
ecx5 5hxd
10 Jun 22
Morphic Holding / NORBERT W BISCHOFBERGER ownership change
7:00pm
4
fmqd3cjbu1ool1fs
10 Jun 22
Morphic Holding / Gustav Christensen ownership change
7:00pm
8-K
gq50s
9 Jun 22
Submission of Matters to a Vote of Security Holders
5:03pm
4
rgfgk
7 Jun 22
Morphic Holding / Bruce Rogers ownership change
7:00pm
4
xkc8ik9367vo0vmns uo
17 May 22
Morphic Holding / Bruce Rogers ownership change
9:08pm
8-K
il6blpyoehtvm84z09gz
12 May 22
Morphic Names Bruce Rogers as President of Morphic Therapeutic and Blaise Lippa as Chief Scientific Officer
8:46am
8-K
ay50lyghuyvhkfk
4 May 22
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
8:06am
DEFA14A
55o n7ajr
29 Apr 22
Additional proxy soliciting materials
4:28pm